Off-label use of valves meant for treating aortic stenosis comes with worse outcomes. US operators await dedicated devices.

Remote monitoring and other innovative solutions are needed to get a handle on the more than 80% of patients who experience ...

Five of the six senior officers for the Royal College of Physicians signed a letter asking Sarah Clarke, a cardiologist, to ...

Following earlier work on erythritol, these latest findings boost concerns about not-so-sweet effects of sugar alcohols.

Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.

NEW YORK, NY—A new mitral valve prosthesis—using a polymer designed to minimize the need for long-term anticoagulation—has ...

NEW YORK, NY—Midterm results out to 3 years show that transcatheter aortic valve-in-valve (ViV) replacement for a failed ...

Many medical professional liability (MPL) claims following noninvasive stress testing might be avoided through careful review ...

NEW YORK, NY—Both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) appear to be acceptable treatment options for patients with primary mitral regurgitation ...

The AHA was founded by physicians committed to the outlandish notion that a CVD diagnosis was not a death sentence.

While muscle mass drops with any kind of weight loss, experts argue that the benefits outweigh the risks in those who need it ...

NEW YORK, NY—The vast majority of symptomatic patients with moderate mitral regurgitation (MR) treated with transcatheter ...